Luoxin Pharmaceuticals Group Stock(002793) Stock Price Today

CN Stock MarketDetailed Quotes

002793 Luoxin Pharmaceuticals Group Stock

Watchlist

4.72
+0.43+10.02%

Market Closed Apr 24 15:00 CST

5.13BMarket Cap-5.56P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Even After Rising 12% This Past Week, Luoxin Pharmaceuticals Group Stock (SZSE:002793) Shareholders Are Still Down 70% Over the Past Five Years
Simply Wall StApr 21 22:26 ET
Luoxin Pharmaceuticals Group Stock (002793.SZ) released its first-quarter performance, with a net income of 5.65 million yuan, turning a profit compared to the same period last year.
Luoxin Pharmaceuticals Group Stock (002793.SZ) disclosed the first quarter report for 2025, during the reporting period the company achieved revenue of 4.8...
Zhitong FinanceApr 21 12:39 ET
Luoxin Pharmaceutical: 2024 Annual Report Summary
SZSIApr 21 12:00 ET · Announcements
Luoxin Pharmaceutical: First Quarter Report 2025
SZSIApr 21 12:00 ET · Announcements
Luoxin Pharmaceutical: 2024 Annual Report
SZSIApr 21 12:00 ET · Announcements
Luoxin Pharmaceutical: Earnings Forecast for the First Quarter of 2025
SZSIApr 14 12:00 ET · Announcements

Comments

Moomoo AI

Mar 14, 2024 06:32

Despite poor financial performance and declining revenue, the company's P/S ratio aligns with the industry, suggesting less bearish investors. However, if the P/S falls in line with recent negative growth rates, shareholders may face disappointment. A share price decline could be imminent given the industry's growth forecasts and the company's declining revenue.

Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) 29% Share Price Surge Not Quite Adding Up

Moomoo AI

Feb 28, 2024 12:18

The company's debt is viewed as a risk due to its negative EBIT and significant revenue drop. The balance sheet is deemed unfit and the stock is considered highly risky. The company's use of debt, considering its liabilities and negative earnings, raises concerns.

Here's Why Luoxin Pharmaceuticals Group Stock (SZSE:002793) Can Afford Some Debt

Moomoo AI

Jan 24, 2024 09:54

Despite poor growth, the company trades at a P/S ratio similar to the industry. Investors may be overlooking this, hoping for a business turnaround, risking future disappointment if the P/S falls in line with negative growth rates.

Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) Share Price Not Quite Adding Up

Moomoo AI

Oct 21, 2023 06:43

The company's dropping revenue and EBIT loss reflect negatively on its ability to service its debt. The balance sheet is somewhat strained, requiring careful monitoring. There is a concern over negative free cash flow, making the company's position risky.

We Think Luoxin Pharmaceuticals Group Stock (SZSE:002793) Has A Fair Chunk Of Debt

002793 Luoxin Pharmaceuticals Group Stock

Trade Overview

Capital Trend

News

Comments

Market Insights

Market Headlines

Latest News